Relations Between Pathological Markers and Radioiodine Scan and F-18-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases

Abstract

Purpose The aim of this study was to investigate relationships between the immunohistochemical results and radioiodine scan and F-18-FDG PET findings in papillary thyroid cancer (PTC) patients with recurrent cervical nodal metastases. Methods A total of 46 PTC patients who had undergone a radioiodine scan and/or F-18-FDG PET/CT and a subsequent operation on recurrent cervical lymph nodes were enrolled. Twenty-seven patients underwent F-18-FDG PET/CT, 8 underwent radioiodine scans, and 11 underwent both scans. In all surgical specimens, the immunoexpressions of thyroglobulin (Tg), sodium-iodide symporter (NIS), glucose transporter 1 (Glut-1), and somatostatin receptor 1 and 2A (SSTR1 and SSTR2A) were assessed, and associations between these expressions and radioiodine scan and F-18-FDG PET findings were evaluated. Results Of the 38 patients who underwent F-18-FDG PET/CT, all patients with weak Tg expression had positive F-18-FDG uptake, while only 45 % of the patients with moderate or strong Tg expression showed positive uptake (p= 0.01). The proportion of patients with positive F-18-FDG uptake increased as the degree of Glut-1 expression with luminal accentuation increased. Of the 19 patients who underwent a radioiodine scan, the proportion with positive radioiodine uptake was greater among patients with strong NIS and SSTR2A expression than among patients expressing these markers at weak levels (p= 0.04 for all). All three patients with weak Tg expression were negative for radioiodine uptake. Conclusion The F-18-FDG uptakes of recurrent cervical nodes are related to strong Glut-1 expression with luminal accentuation and weak Tg expression, whereas radioiodine uptake is related to the strong expressions of NIS and SSTR2A.